Fiasp Flextouch

Fiasp Flextouch is a convenient, pre-filled insulin pen designed to deliver rapid-acting insulin (aspart). It effectively manages blood sugar levels immediately after meals, offering quick glucose control in diabetic patients.

Benefits

• It offers faster absorption than regular insulin, lowering blood sugar shortly after injection.
• An easy-to-use pen device provides precise dosing and is ideal for on-the-go use.
• Reduces post-meal glucose spikes, enhancing overall diabetes management.

Dosage

• The dose is individualized based on blood glucose monitoring and is usually injected subcutaneously immediately before or within 20 minutes after starting a meal.
• Suitable for both adults and pediatric patients under medical supervision.

Warnings and Precautions

• Risk of hypoglycemia; monitor blood sugar levels closely.
• Regularly rotate injection sites to prevent skin reactions or lipodystrophy.

Usage Instructions

• The required insulin dose is displayed in the dosing window.
• Inject subcutaneously into the abdomen, thigh, or upper arm; avoid intravenous or intramuscular use.

Storage Information

• Store unopened pens at 2°C–8°C (refrigerated), away from freezing.
• Opened pens may be stored at room temperature (below 30°C) and must be discarded after 28 days.

Common Side Effects

• Mild: Hypoglycemia symptoms (sweating, hunger, shaking), injection-site redness.
• Serious: Severe hypoglycemia or allergic reactions require immediate medical attention.

More information about Fisap

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide